RPG LIFE SCIENCES share price has zoomed 7% and is presently trading at Rs 2,092.2.
Meanwhile, the BSE HEALTHCARE index is at 41,186.3 (up 0.9%).
Among the top gainers in the BSE HEALTHCARE index today are KIMS (up 3.2%) and ALEMBIC PHARMA (up 3.2%).
CAPLIN POINT (down 1.9%) and FDC (down 1.7%) are among the top losers today.
Over the last one year, RPG LIFE SCIENCES has moved up from Rs 1,166.9 to Rs 2,092.2, registering a gain of Rs 925.3 (up 79.3%).
On the other hand, the BSE HEALTHCARE index has moved up from 28,300.0 to 41,186.3, registering a gain of 45.5% during the last 12 months.
The top gainers among the BSE HEALTHCARE index stocks during this same period were Jubilant Pharmova (up 117.1%), GSK Pharma (up 106.6%) and SUVEN PHARMACEUTICALS (up 105.5%).
Dear Reader: If You Invest in Midcap Stocks, this is for You
The BSE Sensex is at 79,301.4 (down 0.2%).
The top losers among the BSE Sensex today are Asian Paints (down 2.3%) and Infosys (down 1.9%). The most traded stocks in the BSE Sensex are Tata Steel and Tata Motors.
In the meantime, NSE Nifty is at 24,225.6 (down 0.3%). Asian Paints and Infosys are among the top losers in NSE NIFTY.
Over the last 12 months, the BSE Sensex has moved up from 65,953.5 to 79,301.4, registering a gain of 13,347.9 points (up 20.2%).
RPG LIFE SCIENCES net profit grew 21.1% YoY to Rs 268 million for the quarter ended June 2024, compared to a profit of Rs 221 million a year ago. Net sales rose 11.9% to Rs 1,654 million during the period as against Rs 1,478 million in April-June 2023.
For the year ended March 2024, RPG LIFE SCIENCES reported 29.6% increase in net profit to Rs 877 million compared to net profit of Rs 676 million during FY23. Revenue of the company grew 13.5% to Rs 5,821 million during FY24.
The current Price to earnings ratio of RPG LIFE SCIENCES, based on rolling 12 month earnings, stands at 37.5.
Equitymaster requests your view! Post a comment on "RPG LIFE SCIENCES Gains 7%; BSE HEALTHCARE Index Up 0.9%". Click here!
Comments are moderated by Equitymaster, in accordance with the Terms of Use, and may not appear
on this article until they have been reviewed and deemed appropriate for posting.
In the meantime, you may want to share this article with your friends!